Search Results - "Gris, C."

Recombinant human FVIIa for reducing the need for invasive second‐line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial by Lavigne‐Lissalde, G., Aya, A. G., Mercier, F. J., Roger‐Christoph, S., Chauleur, C., Morau, E., Ducloy‐Bouthors, A. S., Mignon, A., Raucoules, M., Bongain, A., Boehlen, F., Moerloose, P., Bouvet, S., Fabbro‐Peray, P., Gris, J.‐C.

“…Summary Background Case reports on recombinant human factor VIIa (rhuFVIIa) use in women with severe postpartum hemorrhage (PPH) showed encouraging results,…”
Get full text

Design and evaluation of braced touch for touchscreen input stabilisation by Cockburn, A., Masson, D., Gutwin, C., Palanque, P., Goguey, A., Yung, M., Gris, C., Trask, C.

“…•Introduces and analyses the design of Braced Touch for touch input stabilisation during vibration.•Describes an empirical validation of Braced Touch using…”
Get full text

Reliability of hemostasis biomarkers is affected by time‐dependent intra‐patient variability by Bouvier, S., Bastide, S., Chouirfa, S., Nouvellon, É., Mercier, É., Bigot, L., Lavigne, G., Cayla, G., Pérez‐Martin, A., Gris, J.‐C.

“…Essentials Nucleosomes and free DNA are two newly described biomarkers in venous thromboembolism (VTE). Reliability of nucleosomes, plasma free DNA and…”
Get full text

Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state by Makatsariya, A. D., Slukhanchuk, E. V., Bitsadze, V. O., Khizroeva, J. K. H., Tretyakova, M. V., Tsibizova, V. I., Elalamy, I., Gris, J.-C., Grandone, E., Makatsariya, N. A., Mashkova, T.

“…For last months, humanity has faced a formidable unknown enemy, which is presented as a new coronavirus infection. Despite the fact that the causative agents…”
Get full text

Engineering issues related to the development of a recommender system in a critical context: Application to interactive cockpits by Bouzekri, E., Canny, A., Fayollas, C., Martinie, C., Palanque, P., Barboni, E., Deleris, Y., Gris, C.

“…•Identification of requirements for engineering critical recommender systems.•Presentation of a generic software architecture for recommender systems.•Proposal…”
Get full text

The hidden activism of the misnamed by Gris, J.‐C.

Get full text

Peripartum bleeding management in a patient with CalDAG‐GEFI deficiency by Canault, M., Saultier, P., Fauré, S., Poggi, M., Nurden, A. T, Nurden, P., Morange, P. E., Alessi, M‐C., Gris, J‐C.

Get full text

Antiphospholipid antibodies and the risk of severe and non‐severe pre‐eclampsia: the NOHA case‐control study by Marchetti, T., Moerloose, P., Gris, J.C.

“…Essentials We studied the incidence of antiphospholipid antibodies (aPLs) in women with previous pre‐eclampsia. Plasma was tested for classical aPLs and other…”
Get full text

Observational study of pregnant women with a previous spontaneous abortion before the 10th gestation week with and without antiphospholipid antibodies by CHAULEUR, C., GALANAUD, J.‐P., ALONSO, S., COCHERY‐NOUVELLON, E., BALDUCCHI, J.‐P., MARÈS, P., FABBRO‐PERAY, P., GRIS, J.‐C.

“…Background: A clinical subtype of purely obstetrical antiphospholipid antibody (aPL‐Ab) syndrome (APS) requires three or more unexplained consecutive embryonic…”
Get full text

Association of -592C/A, -819C/T and -1082A/G interleukin-10 promoter polymorphisms with idiopathic recurrent spontaneous abortion by Zammiti, W., Mtiraoui, N., Cochery-Nouvellon, E., Mahjoub, T., Almawi, W.Y., Gris, J.-C.

“…Increasing evidence supports a role for altered T helper 1 (Th1)–Th2 cytokine balance in idiopathic recurrent spontaneous abortion (RSA). The aim of this study…”
Get full text

Heparin promotes soluble vascular enothelial growth factor receptor expression in human placental villi: a rebuttal by GRIS, J.‐C., MARÈS, P.

“…See also Drewlo S, Levytska K, Sobel M, Baczyk D, Lye SJ, Kingdom JCP. Heparin promotes soluble VEGF receptor expression in human placental villi to impair…”
Get full text

Some hemostasis variables at the end of the population distributions are risk factors for severe postpartum hemorrhages by CHAULEUR, C., COCHERY‐NOUVELLON, E., MERCIER, E., AYA, G., FABBRO‐PERAY, P., MISMETTI, P., LISSADE‐LAVIGNE, G., GRIS, J.‐C.

“…Background: Severe postpartum hemorrhages (PPH) represent a significant cause of maternal morbidity/mortality, but little is known about its hemostasis‐related…”
Get full text

Evaluation of the non-compliance with grouping guidelines which may lead to “wrong blood in tube”, an observational study and risk factor analysis by Daurat, A., Boudet, E., Daurat, G., Roger, C., Gris, J.-C., Tunez, V., Gaste, M.-C., Lefrant, J.-Y.

“…In France, blood group determination requires the completion of two samples collected at two different times to detect identity mistake and “wrong blood in…”
Get full text

Association of the FTO gene with obesity and the metabolic syndrome is independent of the IRS-2 gene in the female population of Southern France by Attaoua, R, Ait El Mkadem, S, Lautier, C, Kaouache, S, Renard, E, Brun, J.-F, Fedou, C, Gris, J.-C, Bringer, J, Grigorescu, F

“…Abstract Aim The objective of the present study was to investigate the genetic association of the fat-mass-and-obesity-associated ( FTO ) gene in obese women…”
Get full text

Simple coagulation tests improve survival prediction in patients with septic shock by LISSALDE‐LAVIGNE, G., COMBESCURE, C., MULLER, L., BENGLER, C., RAILLARD, A., LEFRANT, J.‐Y., GRIS, J.‐C.

“…Background: Classic mortality prediction models in intensive care units (ICUs) are based on clinical scores, which do not contain any coagulation test (SAPS‐II…”
Get full text

Clinical significance of hemostasiological screening for thrombophilia in pregnant women with former thrombosis by Khizroeva, J. Kh, Babaeva, N. N., Makatsariya, N. A., Elalamy, I., Gris, J-C.

“…Introduction. Pregnancy management in post-thrombotic women is challenging, because women with previous episode of venous thromboembolic complications (VTEC)…”
Get full text

ISTH overt disseminated intravascular coagulation score in patients with septic shock: automated immunoturbidimetric soluble fibrin assay vs. D‐dimer assay by GRIS, J.‐C., FAILLIE, J.‐L., COCHERY‐NOUVELLON, É., LISSALDE‐LAVIGNE, G., LEFRANT, J.‐Y.

Get full text

Antiphospholipid antibodies as a potential factor of tumor progression by Aslanova, Z. D., Khizroeva, J. Kh, Solopova, A. G., Bitsadze, V. O., Vorobev, A. V., Gris, J.-C., Elalamy, I., Makatsariya, N. A., Zabolotnaya, D. Yu

“…Introduction . Current generally accepted clinical and laboratory criteria for antiphospholipid syndrome (APS) have been clearly determined, which include…”
Get full text

Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients by Cervera, R, Serrano, R, Pons-Estel, G J, Ceberio-Hualde, L, Shoenfeld, Y, de Ramón, E, Buonaiuto, V, Jacobsen, S, Zeher, M M, Tarr, T, Tincani, A, Taglietti, M, Theodossiades, G, Nomikou, E, Galeazzi, M, Bellisai, F, Meroni, P L, Derksen, R H W M, de Groot, P G D, Baleva, M, Mosca, M, Bombardieri, S, Houssiau, F, Gris, J-C, Quéré, I, Hachulla, E, Vasconcelos, C, Fernández-Nebro, A, Haro, M, Amoura, Z, Miyara, M, Tektonidou, M, Espinosa, G, Bertolaccini, M L, Khamashta, M A

“…To assess the prevalence of the main causes of morbi-mortality in the antiphospholipid syndrome (APS) during a 10-year-follow-up period and to compare the…”
Get more information

Clinical significance of determining neutrophil extracellular traps in women with oncogynecological neoplasms by Aslanova, Z. D., Khizroeva, J. Kh, Solopova, A. G., Solodkiy, V. A., Vorobev, A. V., Blinov, D. V., Aslanova, M. D., Nakaidze, I. A., Gris, J.-C., Elalamy, I., Makatsariya, A. D.

“…The formation of neutrophil extracellular traps (NETs), described first in 2004 as a previously unknown neutrophil strategy for combating microbes, has been…”
Get full text